AM Chemicals

AM Chemicals is a privately-held, revenue-generating company that has been a key enabler in the oligonucleotide synthesis field since 2003. It operates as a platform technology company, providing essential, IP-protected chemical tools—universal solid supports, functional phosphoramidites, and specialized reagents—that improve the synthesis of therapeutic oligonucleotides like antisense and siRNA drugs. With a strong intellectual property portfolio, distribution through partners like Glen Research, and a seasoned leadership team, the company is well-positioned within the growing oligonucleotide therapeutics market. Its business model focuses on selling high-purity reagents and offering specialized radiolabeling services to drug developers.

Proprietary chemistry for oligonucleotide synthesis, including universal solid supports, non-nucleosidic phosphoramidites for functionalization, and the DDTT sulfurization reagent.

AM Chemicals competes with large life science reagent suppliers (e.g., Merck, Thermo Fisher) and specialized oligonucleotide chemistry vendors (e.g., Glen Research, its distributor, also a competitor in some areas). Its differentiation lies in its focused IP portfolio, high-quality specialized products like DDTT and universal supports, and deep technical expertise in oligonucleotide chemistry.